NASDAQ Companies

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. […]

Ms. Nassif brings an extensive track record of successfully developing commercial strategies for multiple FDA-approved drugs Appointment initiates Cassava’s commercial […]

FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, […]

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”), the leading serial acquirer of private […]

ALLO-329 Induces Deep, Transient Depletion of CD19+ B Cells and CD70+ T Cells, and Reduction in IgG and IgM without […]

LEHI, Utah, Nov. 18, 2024 (GLOBE NEWSWIRE) — Blue Raven Solar (“BRS”) a division of Complete Solar Holdings, Inc. (“Complete […]

KISSIMMEE, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), […]

LAS VEGAS, Nov. 18, 2024 (GLOBE NEWSWIRE) — Jet.AI (the “Company”) (Nasdaq: JTAI), an innovative private aviation and artificial intelligence (“AI”) […]

HAUPPAUGE, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of […]

NEW YORK and KUALA LUMPUR, Malaysia, Nov. 18, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or […]